CXCL8 and chronic obstructive pulmonary disease: These dose response and time course experiments found that 10 μg/mL LPS treatment resulted in a statistically significant increase of IL-8, but not LTB4 and PGE2, in COPD BES (p < 0.001) by comparison to non-COPD BES.